09
August
2023
|
10:00 AM
America/New_York

HSS Announces Leadership Successions in Specialties of Joint and Pediatric Surgery

David J. Mayman, MD appointed Chief of Adult Reconstruction and Joint Replacement; Daniel W. Green, MD, MS named Chief of Pediatric Orthopedic Surgery

Hospital for Special Surgery (HSS), the world's leading academic medical center focused on musculoskeletal health, today announced the appointments of David J. Mayman, MD, as chief of the Adult Reconstruction and Joint Replacement (ARJR) Service and Daniel W. Green, MD, MS, as chief of the Pediatric Orthopedic Surgery Service.

Dr. Mayman will succeed Mathias P. Bostrom, MD, who, along with sports medicine surgeon Answorth A. Allen, MD, was recently appointed Associate Surgeon-in-Chief at HSS after serving as ARJR chief for the past four years. Dr. Green will succeed Roger F. Widmann, MD, who has led the Pediatric Surgical Service since 2004. Dr. Widmann will continue to care for pediatric patients with spine and limb deformities and will lead a new center of excellence dedicated to robotic-assisted surgery at HSS. Both appointments will go into effect September 5.

“We are grateful to Drs. Bostrom and Widmann for their steadfast leadership over the years,” said Bryan T. Kelly, MD, MBA, president, surgeon-in-chief and medical director of HSS. “Drs. Mayman and Green are not only talented surgeons, they are collaborative leaders who bring a wealth of expertise and experience to their new roles. These appointments will allow us to continue to advance excellence for our joint replacement and pediatric surgical patients.”

In their new roles, Drs. Mayman and Green will each lead highly integrated multidisciplinary teams. The ARJR service is comprised of programs focused on hip and knee osteoarthritis and other problems requiring joint replacement in adults, while Pediatrics covers the spectrum of conditions requiring orthopedic surgery in children, ranging from sports medicine injuries and trauma to congenital issues of the spine and hip.

David Mayman

David J. Mayman, MD, is an orthopedic surgeon specializing in hip and knee replacements. A member of the Hip and Knee Societies, Dr. Mayman is a leader in the field of robotic and navigated joint replacement surgery. His primary research interest lies in incorporating new technologies into arthroplasty, with the goal of achieving more favorable outcomes for patients.

“I’m honored to take on this new role, leading and collaborating with a deeply talented team of surgeons in order to deliver scientific breakthroughs and address joint pain challenges,” said Dr. Mayman. “HSS is recognized as the leader in joint replacement, and by harnessing the power of our musculoskeletal expertise, we will advance the overall health and wellness of generations to come.” 

Daniel Green

Daniel W. Green, MD, MS, is a pediatric orthopedic surgeon specializing in knee surgery.

A holder of the Mary Kathryn and Alexander Navab Chair for Pediatric Orthopedic Research at HSS, Dr. Green’s clinical research has focused on surgical outcomes and techniques used to treat patella dislocation, osteochondritis dissecans, discoid meniscus and pediatric ACL tears.

“I am honored to be asked to represent such a talented group of pediatric orthopedic surgeon leaders dedicated to taking care of children at the hospital ranked no. 1 in the world for orthopedics,” said Dr. Green. “We are positioned to maintain our leadership position as national and international thought leaders and dedicated to increasing access to our care.”

“HSS is home to an unparalleled number of talented and knowledgeable experts who specialize in caring for patients with various conditions throughout the lifespan,” said Louis A. Shapiro, CEO of HSS. “These appointments highlight the depth of leadership and experience across each area of the organization.”
 

About HSS

HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 14th consecutive year), No. 2 in rheumatology by U.S. News & World Report (2023-2024), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report “Best Children’s Hospitals” list (2023-2024). In a survey of medical professionals in more than 20 countries by Newsweek, HSS is ranked world #1 in orthopedics for a fourth consecutive year (2023). Founded in 1863, the Hospital has the lowest readmission rates in the nation for orthopedics, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center five consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnose, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Innovation Institute works to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu.